Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, irbesartan-containing products
The MHRA has issued a Medicines Recall for specific batches of products supplied by the Marketing Authorisation Holders and parallel distributor companies due to presence of a mutagenic impurity. [Please note that a batch expiry date has been updated on 13th August - see note below for further details]
Published